dievini Hopp BioTech holding GmbH & Co. KG
  • Welcome
  • Management
  • Portfolio
  • News
  • Imprint
  • Data Protection
  • Deutsch
dievini Hopp BioTech holding GmbH & Co. KG
  • Welcome
  • Management
  • Portfolio
  • News
  • Imprint
  • Data Protection
  • Deutsch

March 19, 2021: Heidelberg Pharma AG

Inside information pursuant to Article 17 MAR

Heidelberg Pharma AG Secures Financing Commitment From its Main Shareholder dievini

Heidelberg Pharma AG today announced that it has secured a financing commitment from its main shareholder dievini Hopp BioTech holding GmbH & Co. KG, Walldorf, Germany, (dievini). dievini will provide the Company with up to EUR 30 million. The detailed form of the financing will be decided by the management and supervisory boards of Heidelberg Pharma as well as dievini at a later date.

The financing commitment will enable Heidelberg Pharma to advance its business activities, in particular to conduct the clinical Phase I/IIa of the HDP-101 and to further develop the candidates HDP-102 und HDP-103. Based on the current planning, the Company’s cash reach is secured until mid-2022.

Please read the whole article here

Heidelberg Pharma AG, News 2021
March 19, 2021: Cosmo Pharmaceuticals NV
March 22, 2021: CureVac AG

dievini Hopp BioTech holding GmbH & Co. KG | Impressum | Datenschutz